Statistics
Publications
4
Citations
370
H-Index
4
Active since
2022
Affiliations
Amber M. Amparo is an author at University of North Carolina at Chapel Hill specializing in molecular oncology, medicine, and oncology.
Publications per year
2022–2024
4
4
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text
Medicine, Oncology, Pharmacology +17
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer
Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 160 citations · Full text
Medicine, Oncology, Pharmacology +17
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Szu-Aun Long, Amber M. Amparo, Grace Goodhart et al. · Frontiers in Oncology · 2024 · 23 citations · Full text
Medicine, Oncology, Pharmacology +17
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.
Mareen Lüthen, Jennifer E. Klomp, Bjoern Papke et al. · UNC Libraries · 2024 · 12 citations · Full text
Medicine, Oncology, Pharmacology +15
1–4 of 4